These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28437786)

  • 1. The Effect of Retraining on Treatment Success, Quality of Life, and Metabolic Parameters in Patients with Type 1 Diabetes Using an Insulin Pump.
    Ozgen Saydam B; Yilmazmis F; Aydin N; Bektas B; Yilmaz S; Cavdar U; Ozisik S; Akinci B
    Med Princ Pract; 2017; 26(4):325-330. PubMed ID: 28437786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Insulin Pump Devices in Real Life: The AWeSoMe Study Group Prospective Experience.
    Rachmiel M; Levy-Shraga Y; Gruber N; Pinhas-Hamiel O; Barash G; Pivko-Levy D; Landau Z
    Diabetes Technol Ther; 2019 Mar; 21(3):138-145. PubMed ID: 30702335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.
    DeVries JH; Snoek FJ; Kostense PJ; Masurel N; Heine RJ;
    Diabetes Care; 2002 Nov; 25(11):2074-80. PubMed ID: 12401759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
    Nixon R; Pickup JC
    Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parental mastery of continuous subcutaneous insulin infusion skills and glycemic control in youth with type 1 diabetes.
    Mitchell K; Johnson K; Cullen K; Lee MM; Hardy OT
    Diabetes Technol Ther; 2013 Jul; 15(7):591-5. PubMed ID: 23799273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Sensor-Augmented Insulin Pump Therapy Versus Continuous Insulin Infusion in Patients with Type 1 Diabetes in Turkey.
    Roze S; Smith-Palmer J; de Portu S; Özdemir Saltik AZ; Akgül T; Deyneli O
    Diabetes Technol Ther; 2019 Dec; 21(12):727-735. PubMed ID: 31509715
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of short-term usage of real time continuous glucose monitoring system in achieving metabolic control improvement in adolescents with type 1 diabetes].
    Głowińska-Olszewska B; Jabłońska J; Otocka A; Florys B; Jamiołkowska M; Tobiaszewska M; Semeran K; Peczyńska J; Łuczyński W; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2011; 17(4):179-87. PubMed ID: 22248777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic Index, Extended Bolusing, and Diabetes Education in Insulin Pump Therapy (GLIDE: A Pilot Study).
    Rilstone S; Reddy M; Oliver N
    Diabetes Technol Ther; 2019 Aug; 21(8):452-455. PubMed ID: 31140833
    [No Abstract]   [Full Text] [Related]  

  • 10. Experiences and real life management of insulin pump therapy in adults with type 1 diabetes.
    Quirós C; Jansà M; Viñals C; Giménez M; Roca D; Escarrabill J; Garcia F; Pérez S; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):117-123. PubMed ID: 30076125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
    Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
    Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
    Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
    Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.
    Conget I; Battelino T; Giménez M; Gough H; Castañeda J; Bolinder J;
    Diabetes Technol Ther; 2011 Jan; 13(1):49-54. PubMed ID: 21175271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin pump therapy with continuous glucose monitoring improves metabolic control in brittle type 1 diabetes.
    Petrovski G; Dimitrovski C; Milenkovic T
    Prilozi; 2007 Jul; 28(1):129-35. PubMed ID: 17921923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter user evaluation of ACCU-CHEK® Combo, an integrated system for continuous subcutaneous insulin infusion.
    Kerr D; Hoogma RP; Buhr A; Petersen B; Storms FE;
    J Diabetes Sci Technol; 2010 Nov; 4(6):1400-7. PubMed ID: 21129336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of therapy with continuous subcutaneous insulin infusion in an academic diabetes clinic.
    Rudolph JW; Hirsch IB
    Endocr Pract; 2002; 8(6):401-5. PubMed ID: 15251828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of factors associated with glycaemic control in adults with Type 1 diabetes mellitus on insulin pump therapy.
    Wen W; Frampton R; Wright K; Fattore S; Shadbolt B; Perampalam S
    Diabet Med; 2016 Feb; 33(2):231-4. PubMed ID: 26484625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ProAct study: new features of insulin pumps improve diabetes management and glycemic control in patients after transition of continuous subcutaneous insulin infusion systems.
    Ziegler R; Tubili C; Chico A; Guerci B; Lundberg E; Borchert M; Löffler A; Bloethner S; Weissmann J; Pfützner A
    Diabetes Technol Ther; 2013 Sep; 15(9):738-43. PubMed ID: 23931739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.